Rivas Sjerra R, Sotolongo Molina I, Martines Sardinjas A, Martines Torres A, Borkes Rodrigues R
Urol Nefrol (Mosk). 1989 Sep-Oct(5):51-3.
The study enrolled 19 patients with acute renal failure (ARF) who underwent 108 sessions of hemodialysis, 2 ultrafiltrations and 1 plasmapheresis. Hemodialysis was performed through the unilateral puncturing of the subclavian vein (which averaged 225 days) by a routine catheter (1.2 mm in diameter) introduced into the vein for the period from 1 to 38 days (13.41 +/- 2.06 days). There was no evidence of complications induced by catheterization. The authors regarded the aforementioned vascular access used for various methods of extracorporeal detoxication in the ARF patients with an alternate blood intake and retrieval through the subclavian catheter as a reliable, available and convenient technique ensuring a sufficient blood flow and satisfactory tolerance by the patients.
该研究纳入了19例急性肾衰竭(ARF)患者,他们接受了108次血液透析、2次超滤和1次血浆置换。血液透析通过将一根常规导管(直径1.2毫米)经锁骨下静脉单侧穿刺进行(平均225天),导管置入静脉的时间为1至38天(13.41±2.06天)。没有证据表明导管插入引发并发症。作者认为,上述用于急性肾衰竭患者多种体外解毒方法的血管通路,通过锁骨下导管交替进行血液输入和回收,是一种可靠、可行且便捷的技术,可确保充足的血流量并使患者具有令人满意的耐受性。